A Series B biotech company faced the challenge of rapid organizational growth while advancing two programs toward late preclinical and clinical-stage development. As hiring demands surged across R&D, clinical development, CMC, and G&A, the company needed a scalable people infrastructure to support expansion, navigate key executive transitions, and maintain a strong, mission-driven culture.
Over the course of three years, we partnered closely with leadership to build the foundation for long-term success. In just 12 months, we tripled the team size, ensuring critical functions were established to drive the company’s next phase of growth. Our strategy included:
- Executive leadership transitions: onboarding a new executive team while integrating key board members.
- A dynamic talent strategy: evolving hiring practices to meet the demands of late preclinical and clinical-stage development.
- Mission-driven cultural reinforcement: refining the company’s values and employee experience to solidify engagement.
- Employer branding enhancements: positioning the company as a leader in biotech talent acquisition.
Through strategic talent scaling, the company achieved:
- Zero regrettable turnover: fostering continuity and stability in a rapidly growing team.
- A recognized culture of excellence: earning a spot as one of San Francisco’s Best Places to Work – one of only five life sciences companies to receive the honor.
- Seamless leadership integration: ensuring alignment from the boardroom to the lab.
By combining people strategy with biotech expertise, this company has successfully built the infrastructure to support innovation while maintaining a thriving, purpose-driven workplace.